Today: 15 May 2026
Ondas (ONDS) Stock Price Rises After BIRD Aerosystems Deal Adds Missile-Defense Tech

Ondas (ONDS) Stock Price Rises After BIRD Aerosystems Deal Adds Missile-Defense Tech

NEW YORK, March 11, 2026, 09:33 EDT

Shares of Nasdaq-listed Ondas Inc. climbed early Wednesday, after the company announced its acquisition of BIRD Aerosystems—bringing new airborne missile-defense and surveillance capabilities into the fold, and extending a recent streak of deal activity. The stock traded 1% higher at $10.11 in premarket action as of 9:04 a.m. EDT, following a 2.98% gain to $10.01 at Tuesday’s close.

That’s notable: Ondas has dropped big defense news three days running, and now investors are watching to see if the small-cap can actually convert deals and incoming orders into steady top-line gains.

Ondas reported that BIRD’s protection systems are already flying on more than 700 aircraft, spanning over 40 different models in service with the U.S. Army, NATO, several Asia-Pacific air forces, and U.N. aviation groups. The acquisition adds missile-defense technology for both drones and piloted planes, plus ISR—intelligence, surveillance and reconnaissance—systems. CEO Eric Brock described BIRD as “an important and highly differentiated capability.” Ondas Inc.

The $15.8 million contract announced Tuesday landed via 4M Defense, Ondas’s demining arm based in Israel. According to the company, this is just the first phase of a broader land-clearance push near the Israel-Syria border, a project valued at more than $30 million—and possibly stretching to $60 million in total. 4M is set to deploy robots, drones, and specialized sensors to locate and defuse explosives in the area. “Smart demining technologies are transforming the way governments approach land-clearance missions,” said Oshri Lugassy, co-CEO of Ondas Autonomous Systems. Ondas Inc.

Ondas said Monday it expects fourth-quarter revenue to land between $29.1 million and $30.1 million, edging past earlier projections. For all of 2025, the company now anticipates revenue of $49.7 million to $50.7 million—again beating its previous forecast. The 2026 revenue target is unchanged at $170 million to $180 million, a figure that does not count acquisitions revealed this year.

That day, the company struck a deal to acquire private U.S. defense firm Mistral, paying $175 million in stock. Ondas said taking over Mistral puts it in position to land work at the Pentagon as a prime contractor—letting it pitch bids directly to the government, no middleman required—and opens the door to over $1 billion in Defense Department contract vehicles and programs.

Stifel’s Jonathan Siegmann kept his Buy call and held the $18 target following the merger and revenue update. “Better Q4 revenues + adding new manufacturing platform validates positive thesis,” Siegmann said. He noted the merged company could nearly double Ondas’s 2026 revenue base and potentially deliver positive EBITDA—operating profit before interest, taxes, and non-cash charges—sooner, within 2026. Investing.com

Defense-drone stocks haven’t all tracked together. AeroVironment slid roughly 10% in premarket trading Wednesday following its outlook cut. On Tuesday, according to Barron’s, shares of both AeroVironment and Kratos Defense also declined.

Ondas is moving fast, but there’s risk in that speed. According to a filing, the Mistral merger still isn’t a done deal—closing conditions remain, and there’s a May 9 outside date. Since the entire purchase is in stock, shareholders could see dilution, especially if integration drags or new orders take longer to translate into revenue than optimistic estimates suggest.

March 25 is circled as the next crucial date. That’s when Ondas will deliver its final 2025 results and share new outlook details for BIRD. For investors watching to see if the company’s push into defense is translating into actual bookings, this update may matter more than whatever headlines cross the wire.

Stock Market Today

  • Invesco QQQ Sees $971.7 Million ETF Inflows; TMUS, AMGN, STX Performance Mixed
    May 15, 2026, 11:22 AM EDT. The Invesco QQQ Trust (QQQ) recorded a notable ETF inflow of approximately $971.7 million, representing a 0.2% increase in units week-over-week. Key components showed mixed trading today: T-Mobile US (TMUS) rose 0.2%, Amgen (AMGN) dropped 1.2%, and Seagate Technology (STX) declined 2.5%. QQQ shares last traded at $710.84, near their 52-week high of $722.03, and remain above the 200-day moving average, a common technical indicator used to assess trend direction. ETF unit creation indicates increased buying of underlying assets, potentially impacting component stocks. This inflow reflects ongoing investor demand in the technology-heavy Nasdaq 100 tracking fund.

Latest articles

Plug Power Stock Drops Again: The $5 Billion Hydrogen Turnaround Faces Its Cash Test

Plug Power Stock Drops Again: The $5 Billion Hydrogen Turnaround Faces Its Cash Test

15 May 2026
Plug Power shares fell 1.7% to $3.725 in early Nasdaq trading Friday, following a volatile week after first-quarter results. The company reported a 22% revenue increase to $163.5 million and improved gross margin, but its net loss widened to $245.3 million and operating cash use rose to $150 million. Plug ended March with $802 million in cash and expects $142 million from a hydrogen asset sale in June.
Why Ford Motor Company Stock Is Sliding After Its AI Data Center Rally

Why Ford Motor Company Stock Is Sliding After Its AI Data Center Rally

15 May 2026
Ford shares dropped 7% to $13.43 in early Friday trading, reversing part of a rally sparked by the launch of its new Ford Energy unit. The subsidiary, announced this week, will sell large battery energy storage systems to utilities and data centers, with first deliveries expected in late 2027. CEO Jim Farley said Ford is in the contracting phase with several customers. The stock had surged 13% Wednesday after Morgan Stanley highlighted the business.
Biogen Closes Apellis Deal; APLS Leaves Nasdaq As $5.6 Billion Rare-Disease Bet Begins

Biogen Closes Apellis Deal; APLS Leaves Nasdaq As $5.6 Billion Rare-Disease Bet Begins

15 May 2026
Biogen has closed its acquisition of Apellis Pharmaceuticals, making Apellis a wholly owned subsidiary and delisting its shares from Nasdaq. Apellis shareholders receive $41 per share in cash plus a contingent value right tied to Syfovre sales. Biogen gains the drugs Empaveli and Syfovre, and expands into kidney disease. Biogen borrowed $2 billion to help finance the deal.
Nokia Oyj Stock Pulls Back After AI Rally: What Investors Need to Know

Nokia Oyj Stock Pulls Back After AI Rally: What Investors Need to Know

15 May 2026
Nokia’s U.S.-listed shares dropped about 5% Friday, trading at $13.74 after a recent AI-driven surge. The decline followed a rally sparked by Cisco’s report of $5.3 billion in AI infrastructure orders from hyperscalers. Nokia saw a 54% jump in first-quarter operating profit and named Siemens’ Emma Falck as president of Mobile Infrastructure, effective September 1.
UiPath secures AIUC-1 AI-agent safety certification ahead of earnings as investors await proof
Previous Story

UiPath secures AIUC-1 AI-agent safety certification ahead of earnings as investors await proof

Opendoor Stock Falls 6% as Rising Rate Fears, Weak Housing Data Hit OPEN Shares
Next Story

Opendoor Stock Falls 6% as Rising Rate Fears, Weak Housing Data Hit OPEN Shares

Go toTop